Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Open Angle Glaucoma or Ocular Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01568008
What this trial is testing

Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Allergan 933
Early research (Phase 1)Study completedNCT03131167
What this trial is testing

Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma

Who this might be right for
Primary Open-angle Glaucoma (POAG)Ocular Hypertension
Shire 63
Not applicableStudy completedNCT04828057
What this trial is testing

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting

Who this might be right for
Ocular Surface DiseasePrimary Open Angle Glaucoma
Santen Pharmaceutical (Taiwan) Co., LTD 50
Large-scale testing (Phase 3)Study completedNCT00230763
What this trial is testing

Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure

Who this might be right for
Glaucoma, Primary Open Angle (POAG)Ocular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 396
Large-scale testing (Phase 3)Study completedNCT01217606
What this trial is testing

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 185
Not applicableLooking for participantsNCT07076303
What this trial is testing

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

Who this might be right for
Primary Open Angle GlaucomaGlaucomaPrimary Open Angle Glaucoma or Ocular Hypertension
Brian Shafer 60
Not applicableStudy completedNCT01646151
What this trial is testing

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 2,580
Testing effectiveness (Phase 2)Study completedNCT02371746
What this trial is testing

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Who this might be right for
Glaucoma and Ocular Hypertension
Envisia Therapeutics 41
Not applicableStudy completedNCT01252849
What this trial is testing

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Who this might be right for
Primary Open Angle Glaucoma (POAG)
Glaukos Corporation 119
Not applicableStudy completedNCT01853085
What this trial is testing

Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

Who this might be right for
Glaucoma, Primary Open AngleOcular Hypertension
Allergan 1,830
Large-scale testing (Phase 3)Study completedNCT05022004
What this trial is testing

A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Sun Pharmaceutical Industries Limited 599
Testing effectiveness (Phase 2)Study completedNCT03216902
What this trial is testing

A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study

Who this might be right for
Open-angle Glaucoma, Ocular Hypertension
Santen Inc. 241
Not applicableUnknownNCT04891588
What this trial is testing

Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Klinički Bolnički Centar Zagreb 50
Not applicableStudy completedNCT02544646
What this trial is testing

Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG

Who this might be right for
GlaucomaPrimary Open Angle GlaucomaPseudoexfoliation Glaucoma
Medical University of Vienna 53
Testing effectiveness (Phase 2)Study completedNCT00868894
What this trial is testing

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Santen Inc. 49
Not applicableStudy completedNCT05181046
What this trial is testing

Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients

Who this might be right for
GlaucomaGlaucoma, Open-AngleGlaucoma, Primary Open Angle+2 more
Nanodropper, Inc. 420
Testing effectiveness (Phase 2)Study completedNCT00650702
What this trial is testing

Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Mati Therapeutics Inc. 36
Post-approval studies (Phase 4)Study completedNCT02017327
What this trial is testing

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratoires Thea 379
Testing effectiveness (Phase 2)Study completedNCT01915940
What this trial is testing

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 169
Large-scale testing (Phase 3)Study completedNCT04620135
What this trial is testing

Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Aerie Pharmaceuticals 245
Next Page